INDEGENE - A potential recent IPO listed pick
A life sciences commercialization company, recently listed in may'24. Company has
1. Been profitable and poised for the growth trajectory
2. Good sales expansion
3. Business space is kind of a moat
4. Excellent support zone as indicated
5. Excellent ROCE and operating margins
1. Been profitable and poised for the growth trajectory
2. Good sales expansion
3. Business space is kind of a moat
4. Excellent support zone as indicated
5. Excellent ROCE and operating margins
交易开始
A proxy for life sciences/pharma cos investment!
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。